Uncategorized
Clinical Specialties recalls Avastin unit dose syringes
Clinical Specialties Compounding Pharmacy has voluntarily issued a nationwide recall of Avastin unit dose syringes after it received five reports of intraocular infections, according to a press release from the U.S. Food and Drug Administration. The recall covers 79 lots of Avastin (bevacizumab, Genentech) distributed to physicians’ offices in Georgia, Louisiana, South Carolina and Indiana from Dec. 18, 2012, to the present, the release said.